Optimising the use of Azathioprine in the treatment of Inflammatory Bowel Disease
Azathioprine (AZA) and mercaptopurine (MP – also known as 6-mercaptopurine or 6MP) are the first line immunomodulatory treatments for inflammatory bowel disease (IBD) with proven efficacy for multiple clinical outcomes (fistula closure, steroid withdrawal, maintenance of remission etc.). They also h...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.695738 |